FRAXA background

20
JUL
2015
Claudia Bagni, PhD, at University of Rome, FRAXA research grant

At a crossroads of Fragile X and Alzheimers Research

Researchers investigate treatment targets which may address both Fragile X Syndrome and Alzheimer’s disease Last week researchers at VIB Leuven in Belgium published...
16
JUL
2015

Survey for Parents of Children with Fragile X Syndrome

Researchers at the University of South Carolina are looking for parents who have at least one child or adult with Fragile X to participate in a survey regarding their...
24
JUN
2015
Alcobra logo

Fragile X Clinical Trial Results of metadoxine by Alcobra

Metadoxine for Fragile X – a glimmer of hope Alcobra just announced results from their trial of a proprietary formulation of metadoxine in Fragile X Syndrome subjects,...
03
JUN
2015
Patrick's Pals raised funds for Fragile X

Patrick’s Pals raise $160,000 for Fragile X

19th Annual Basketball tournament to raise funds for Fragile X research Patrick’s PALS 3-on-3 Basketball Tournament turned 19 on May 30th, 2015! 32 teams suited up to...
02
JUN
2015
Michael Tranfaglia, FRAXA Medical Director

Fragile X: Past, Present, Future – Video

Fragile X Presentation by Michael Tranfaglia, MD, FRAXA Medical Director IDD-C conference – Stanford University – April 21, 2015 In-depth discussion of how...
28
MAY
2015
Bruins $90,000 donation to FRAXA for Fragile X research grant

Boston Bruins Grant Funds New Fragile X Research

Boston Bruins Foundation’s $90,000 commitment to FRAXA Bruins Foundation Executive Director Bob Sweeney pledging a $90,000 donation to FRAXA Research today at Shared Living...
08
APR
2015
Qionger He, PhD, and Anis Contractor, PhD

FRAXA Funds 2015 Fragile X Research Projects

New 2015 Fragile X research projects have launched!  FRAXA’s mission reaches beyond funding high-quality basic science. We are essentially trying to engineer a Fragile X cure...
12
MAR
2015

Fragile X Treatment: New Research Directions

Re-examining the Nature of Fragile X by Michael Tranfaglia, MD FRAXA Medical Director In the wake of negative results from several high-profile clinical trials in Fragile X,...